The Cardio IQ™ Diabetes Risk Panel with Score combines advanced biomarker analysis to evaluate insulin resistance, lipid metabolism, and glycemic control. This panel generates a diabetes risk score that helps identify individuals at increased risk for type 2 diabetes and related cardiometabolic complications. It provides insight into metabolic health, supporting early intervention, lifestyle planning, and long-term disease management.

The Cardio IQ™ Diabetes and ASCVD Risk Panel with Scores measures advanced cardiovascular and metabolic markers to evaluate risk for atherosclerotic cardiovascular disease and type 2 diabetes. This panel includes lipid analysis, glucose-related biomarkers, and inflammation indicators, helping assess cardiometabolic health. Results provide clinicians with detailed scoring to identify patterns that may influence prevention and long-term disease management.

The Diabetes Risk Panel with Score combines multiple biomarkers to assess risk of developing type 2 diabetes and related metabolic conditions. By evaluating glucose control, insulin resistance, lipid levels, and inflammation markers, this panel provides a personalized score that reflects overall metabolic health. Clinicians use it to help identify individuals at increased risk, support early intervention, and monitor long-term health.

 The DH-1 Diabetes Health panel is specifically curated to provide a foundational assessment of an individual's diabetes status and metabolic health. It includes two essential tests: the Comprehensive Metabolic Panel (CMP) and the Hemoglobin A1c (HbA1c). This panel is designed to give a snapshot of the current glucose control and the body's metabolic state, offering crucial insights for managing diabetes effectively.

 The Diabetes Management - Basic panel is a fundamental tool designed to help monitor and manage diabetes effectively. This panel includes a series of tests that provide a comprehensive overview of a patient's metabolic status, blood glucose control, and kidney function. By assessing these key markers, healthcare providers can evaluate the current state of a patient's diabetes, identify potential complications early, and adjust treatment plans to ensure optimal management of the disease.

 The Diabetes Management - Advanced panel is an extensive diagnostic tool designed to provide a thorough evaluation of a patient’s diabetic status and associated health risks. This panel includes a comprehensive range of tests that assess blood glucose control, kidney function, lipid metabolism, insulin levels, and overall metabolic health. The combination of these tests offers a holistic view of a diabetic patient's condition, enabling healthcare providers to develop effective management and treatment plans.

 The Diabetes Management - Basic Plus panel is an enhanced diagnostic tool designed to provide a more comprehensive assessment of diabetes management compared to the basic panel. This panel includes tests that not only monitor blood glucose control and kidney function but also provide insights into blood health and lipid metabolism. By expanding the range of biomarkers assessed, this panel helps healthcare providers to better understand the overall health status of diabetic patients and to identify potential complications at an early stage.

The DH-2 Diabetes Health panel is an expanded diagnostic tool designed for comprehensive diabetes management and assessment of related health risks. It includes a range of tests: CBC with Differential and Platelets, Comprehensive Metabolic Panel (CMP), Hemoglobin A1c, Lipid Panel, and Random Urine Microalbumin with Creatinine. This panel provides a detailed view of a patient's blood sugar control, kidney function, liver function, lipid levels, and overall health status, making it a valuable resource in managing diabetes and its complications.

 The Diabetes Management - Comprehensive panel is an extensive diagnostic tool designed to provide a thorough evaluation of a patient's diabetic status and associated health risks. This panel includes a broad range of tests that assess blood glucose control, kidney function, lipid metabolism, inflammation, and overall metabolic health. By offering a detailed picture of a diabetic patient's condition, healthcare providers can develop and refine effective management and treatment plans to optimize patient outcomes and prevent complications.

The DH-3 Diabetes Health panel is a comprehensive diagnostic panel designed for an in-depth analysis of diabetes management and its impact on overall health. It includes a series of tests: C-Reactive Protein (CRP), CBC with Differential and Platelets, Comprehensive Metabolic Panel (CMP), Hemoglobin A1c, Insulin, Lipid Panel, and Random Urine Microalbumin with Creatinine. This panel not only assesses blood sugar control and diabetes management but also evaluates cardiovascular risk, kidney function, and the body's insulin production and response.

 The DH-4 Diabetes Health panel is a comprehensive suite of tests tailored for individuals with diabetes, particularly those with complex management needs or those at high risk for complications. This panel includes C-Reactive Protein (CRP), CBC with Differential and Platelets, Comprehensive Metabolic Panel (CMP), 2 Specimen Glucose Tolerance Test, Hemoglobin A1c, Insulin, 2 Specimen Insulin Response to Glucose, Lipid Panel, and Random Urine Microalbumin with Creatinine. It is designed to provide a thorough assessment of diabetes control, cardiovascular risk, insulin function, kidney health, and overall metabolic status.